Mitsui Chemicals recorded net sales of 166.8 billion yen (down 7.8% YoY) for the fiscal year ending March 2026. The net income attributable to parent company shareholders was 3.44 billion yen (up 6.6% YoY), with the segments showing growth in Life & Healthcare Solutions while Mobility Solutions experienced a decline in sales and profit.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4183","jir_company_name":"Mitsui Chemicals, Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-05-13","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/05\/4183-20260513-01.pdf","jir_short_summary":"Mitsui Chemicals recorded net sales of 166.8 billion yen (down 7.8% YoY) for the fiscal year ending March 2026. The net income attributable to parent company shareholders was 3.44 billion yen (up 6.6% YoY), with the segments showing growth in Life & Healthcare Solutions while Mobility Solutions experienced a decline in sales and profit.","jir_summary":"### Performance Overview\nMitsui Chemicals achieved net sales of 166.8 billion yen (down 7.8% YoY) for the fiscal year ending March 2026, with net income attributable to parent company shareholders totaling 3.44 billion yen (up 6.6% YoY). The Life & Healthcare Solutions segment maintained growth in both revenue and profit, while Mobility Solutions experienced a decrease in sales and profit due to lower sales volume. Overall, core operating profit was steady at 100.0 billion yen (down 0.9% YoY), and dividends increased to 37.5 yen. Moving forward, the company aims to enhance business transformation while carefully monitoring raw material prices and currency fluctuations amid global economic uncertainties.\n\n### Outlook and Shareholder Returns\nThe earnings forecast for the fiscal year ending March 2027 anticipates sales of 190.0 billion yen (up 13.9% YoY) and net income of 4.5 billion yen (up 30.9% YoY), with an annual dividend of 75 yen planned. In the medium to long term, Mitsui Chemicals will promote ESG management and optimize its business structure, continuing stable dividends and share buybacks as shareholder return policies. The company will also focus on cost control and fostering new business opportunities to prepare for fluctuations in currency rates and raw material prices.","jir_financial_highlights":"Net Sales: 166.8 billion yen (Down 7.8% YoY)\nNet Income Attributable to Parent Company Shareholders: 3.44 billion yen (Up 6.6% YoY)\nFull-Year Revenue Forecast: 190.0 billion yen (Forecasted +13.9%)","jir_category":"","jir_hashtags":"#MitsuiChemicals, #IRFinancialResults, #JapaneseStocks","jir_key_figures":"Net sales: 166.8 billion yen (down 7.8% YoY)\nNet income attributable to parent company shareholders: 3.44 billion yen (up 6.6% YoY)\nDividend for the fiscal year ending March 2026: 37.5 yen","jir_meta_title":"\u3010Mitsui Chemicals\u30112026 Fiscal Year Financial Results\uff5cSales of 166.8 billion yen (Down 7.8%)","jir_meta_description":"Mitsui Chemicals achieved sales of 166.8 billion yen (down 7.8%) for the fiscal year ending March 2026. Net income was 3.44 billion yen (+6.6%), with insights into future business outlook and dividend policy.","jir_og_title":"\u3010Mitsui Chemicals\u30112026 Fiscal Year Financial Results\uff5cSales of 166.8 billion yen (Down 7.8%)","jir_og_description":"A clear overview of Mitsui Chemicals' 2026 fiscal year results and future outlook. Includes dividend and segment-specific trends.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Sales Trend\", \"jir_chart_json_data\": \"{\\\"labels\\\": [\\\"FY2025\\\", \\\"FY2026\\\"], \\\"datasets\\\": [{\\\"label\\\": \\\"Net Sales (billion yen)\\\", \\\"data\\\": [1668, 166.8], \\\"borderColor\\\": \\\"#3e95cd\\\", \\\"fill\\\": false}]} \"}, {\"jir_chart_id\": \"profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Net Income Trend\", \"jir_chart_json_data\": \"{\\\"labels\\\": [\\\"FY2025\\\", \\\"FY2026\\\"], \\\"datasets\\\": [{\\\"label\\\": \\\"Net Income (billion yen)\\\", \\\"data\\\": [3.44, 3.44], \\\"borderColor\\\": \\\"#8e5ea2\\\", \\\"fill\\\": false}]} \"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"pie\", \"jir_chart_title\": \"Segment Revenue Composition\", \"jir_chart_json_data\": \"{\\\"labels\\\": [\\\"Life & Healthcare Solutions\\\", \\\"Mobility Solutions\\\", \\\"ICT Solutions\\\", \\\"Basic & Green Materials\\\"], \\\"datasets\\\": [{\\\"data\\\": [25.2, 31.0, 15.3, 36.5], \\\"backgroundColor\\\": [\\\"#4e79a7\\\", \\\"#f28e2b\\\", \\\"#e15759\\\", \\\"#76b7b2\\\"]}]} \"}, {\"jir_chart_id\": \"margin_analysis\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Profit Margin Analysis\", \"jir_chart_json_data\": \"{\\\"labels\\\": [\\\"FY2025\\\", \\\"FY2026\\\"], \\\"datasets\\\": [{\\\"label\\\": \\\"Core Operating Margin (%)\\\", \\\"data\\\": [5.0, 5.0], \\\"backgroundColor\\\": \\\"#59a14f\\\"}]} \"}, {\"jir_chart_id\": \"guidance_comparison\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Forecast vs Actual Comparison\", \"jir_chart_json_data\": \"{\\\"labels\\\": [\\\"Sales\\\", \\\"Net Income\\\"], \\\"datasets\\\": [{\\\"label\\\": \\\"Actual\\\", \\\"data\\\": [1668, 3.44], \\\"backgroundColor\\\": \\\"#e15759\\\"}, {\\\"label\\\": \\\"Forecast\\\", \\\"data\\\": [1900, 4.5], \\\"backgroundColor\\\": \\\"#4e79a7\\\"}]} \"}]","ir_related_company":7672,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-48807","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n